Ir para o conteúdo principal

United StatesÚltimas notícias

Grafa
Health

MediBeacon gets FDA approval for next-gen kidney function monitoring system

INNOVATE Corp. (NYSE:VATE) said MediBeacon, in which it holds a 44.7% equity stake, has received U.S. Food and Drug Administration approval for its next-generation MediBeacon TGFR System, introducing a reusable sensor intended to broaden access to point-of-care kidney function assessment.

Leia mais: MediBeacon gets FDA approval for next-gen kidney function monitoring system
Grafa

Cardone Ventures makes unsolicited $89M proposal to acquire PetMed Express

Cardone Ventures, the investment firm led by billionaire Grant Cardone and business partners Brandon and Natalie Dawson, has made an unsolicited, non-binding proposal to acquire PetMed Express (NASDAQ:PETS) for $4.25 per share in cash, implying an equity value of around $89 million.

Leia mais: Cardone Ventures makes unsolicited $89M proposal to acquire PetMed Express
Grafa
Health

Monte Rosa’s MRT-2359 combination shows striking activity in AR-mutant mCRPC subgroup

Monte Rosa Therapeutics (NASDAQ:GLUE) reported encouraging early clinical results for its molecular glue degrader MRT-2359 in combination with enzalutamide, showing pronounced activity in a genetically defined subset of heavily pretreated metastatic castration-resistant prostate cancer (mCRPC).

Leia mais: Monte Rosa’s MRT-2359 combination shows striking activity in AR-mutant mCRPC subgroup